Levels of immune response markers as adverse outcome predictors following biomaterial implant surgery

Moss, Melissa A., Mihyun L. Waugh, Nicholas D. Boltin, Lauren Wolf, Ronnie Horner, Matthew Hermes, Thomas L Wheeler II, Richard L. Goodwin, and Richard Michael Gower. 2023. Levels of immune response markers as adverse outcome predictors following biomaterial implant surgery, issued 2023.

Abstract

 

In general, the present disclosure is directed to systems and methods of evaluating a subject's risk of one or more complications associated with pelvic organ prolapse surgery. The method comprising: obtaining, by a computing system comprising one or more computing devices, sample data associated with the subject; inputting, by the computing system, the sample data into a machine-learned immune response model; receiving, by the computing system as an output of the machine-learned immune response model, one or more predictions of post-surgical complications of mesh exposure through the vaginal wall associated with the subject; and performing a pelvic organ prolapse repair surgery on the subject, wherein the surgery is performed based at least in part on the one or more predictions of post-surgical complications by the machine-learned immune response model associated with a likelihood of success.

Last updated on 06/17/2025